Hill, Andrew F.
Hill, Andrew F. (Andrew Francis)
أندرو إف. هيل
Hill, Andrew Francis
VIAF ID: 26546654 (Personal)
Permalink: http://viaf.org/viaf/26546654
Preferred Forms
- 200 _ | ‡a Hill ‡b Andrew Francis
- 100 1 _ ‡a Hill, Andrew F.
- 100 1 _ ‡a Hill, Andrew F.
-
-
-
- 100 1 _ ‡a Hill, Andrew F.
-
-
-
- 100 1 _ ‡a Hill, Andrew F. ‡q (Andrew Francis)
-
- 100 0 _ ‡a أندرو إف. هيل
4xx's: Alternate Name Forms (11)
5xx's: Related Names (1)
- 551 _ _ ‡a Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute; Department of Pathology and Mental Health Institute of Victoria, University of Melbourne, Melbourne ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
Title | Sources |
---|---|
Exosomes and microvesicles : methods and protocols | |
Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis | |
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection | |
Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles | |
Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. | |
An intact membrane is essential for small extracellular vesicle-induced modulation of α-synuclein fibrillization | |
Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms | |
Intercellular Resistance to BRAF Inhibition Can Be Mediated by Extracellular Vesicle-Associated PDGFRβ. | |
Intracellular itinerary of internalised β-secretase, BACE1, and its potential impact on β-amyloid peptide biogenesis. | |
iSRAP - a one-touch research tool for rapid profiling of small RNA-seq data. | |
Lipid metabolism in patients infected with Nef-deficient HIV-1 strain | |
Malaria parasite DNA-harbouring vesicles activate cytosolic immune sensors. | |
Manganese chelation therapy extends survival in a mouse model of M1000 prion disease | |
Markers of A1 astrocytes stratify to molecular sub-types in sporadic Creutzfeldt-Jakob disease brain | |
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines | |
Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell | |
Misfolded α-synuclein causes hyperactive respiration without functional deficit in live neuroblastoma cells | |
Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of APP and Tau causing neuronal dysfunction | |
Modulation of amyloid precursor protein processing by synthetic ceramide analogues. | |
Molecular and clinical classification of human prion disease | |
Molecular biology of prion propagation. | |
Molecular screening of sheep for bovine spongiform encephalopathy | |
Molecular typing of PrPres in human sporadic CJD brain tissue. | |
Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture | |
Multiple folding pathways for heterologously expressed human prion protein | |
MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin genes | |
Neurotoxicity in Alzheimer's disease: is covalently crosslinked A beta responsible? | |
The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes | |
Not a day without microRNA | |
Novel miR-29b target regulation patterns are revealed in two different cell lines | |
Novel prion protein insert mutation associated with prolonged neurodegenerative illness. | |
Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper | |
Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition | |
Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis | |
Overview and recent advances in neuropathology. Part 2: Neurodegeneration | |
Packaging of prions into exosomes is associated with a novel pathway of PrP processing. | |
Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality | |
PBT2 inhibits glutamate-induced excitotoxicity in neurons through metal-mediated preconditioning | |
Polyalanine expansions drive a shift into α-helical clusters without amyloid-fibril formation. | |
Polyglutamine aggregation in Huntington and related diseases. | |
Possible link between bovine spongiform encephalopathy and sporadic Creutzfeldt-Jakob disease. | |
Prion infection impairs cholesterol metabolism in neuronal cells. | |
The prion protein constitutively controls neuronal store-operated Ca(2+) entry through Fyn kinase | |
Prion protein glycosylation. | |
Prion protein protocols, c2008: | |
Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity. | |
Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. | |
Protease-resistant prion protein produced in vitro lacks detectable infectivity. | |
Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein | |
Protein folding, misfolding, and disease : methods and protocols | |
Proteomic analysis of extracellular vesicles reveals an immunogenic cargo in rheumatoid arthritis synovial fluid | |
PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site. | |
Quantitative Analysis of Exosomal miRNA via qPCR and Digital PCR. | |
Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1. | |
Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein | |
Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. | |
Restraint Stress Alters Expression of Glucocorticoid Bioavailability Mediators, Suppresses Nrf2, and Promotes Oxidative Stress in Liver Tissue | |
Revealing the Proteome of Motor Cortex Derived Extracellular Vesicles Isolated from Amyotrophic Lateral Sclerosis Human Postmortem Tissues | |
Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. | |
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation | |
The role of lipids in α-synuclein misfolding and neurotoxicity. | |
The same prion strain causes vCJD and BSE | |
The secret life of extracellular vesicles in metal homeostasis and neurodegeneration | |
Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide | |
SERF protein is a direct modifier of amyloid fiber assembly. | |
Sex-specific transcriptional and proteomic signatures in schizophrenia | |
Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells--Evidence of unique microRNA cargos | |
Small RNA fingerprinting of Alzheimer's disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles | |
Small RNA Library Construction for Exosomal RNA from Biological Samples for the Ion Torrent PGM™ and Ion S5™ System | |
Species-barrier-independent prion replication in apparently resistant species | |
Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions | |
Strain-specific prion-protein conformation determined by metal ions | |
Subclinical prion infection. | |
Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons. | |
Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017. | |
Towards mechanisms and standardization in extracellular vesicle and extracellular RNA studies: results of a worldwide survey | |
Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool. | |
Type of prion protein in UK farmers with Creutzfeldt-Jakob disease | |
Ubiquitin-like protein 3 (UBL3) is required for MARCH ubiquitination of major histocompatibility complex class II and CD86 | |
Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. | |
Updating the MISEV minimal requirements for extracellular vesicle studies: building bridges to reproducibility. | |
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation | |
Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity |